Iberdomide Promising for Cutaneous Lupus in Phase 2 Study ...Middle East

Medscape - News
In a phase 2 trial, iberdomide was associated with improved symptoms when added to standard lupus medications in patients with subacute and chronic cutaneous lupus erythematosus Medscape Medical News

Hence then, the article about iberdomide promising for cutaneous lupus in phase 2 study was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Iberdomide Promising for Cutaneous Lupus in Phase 2 Study )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News